Company: IONQ
Filing Date: 2025-02-27
Form Type: 424B5
Source: 0001193125-25-037295
Chunk: 8

Company: IonQ, Inc.
Filing Date: 2025-02-27
Form: 424B5
Chunk 8
---
 officers may sell shares of common stock at any time, including during our upcoming open trading window beginning on March 3, 2025. However, during the period between the completion of the
offering pursuant to this prospectus supplement and March 14, 2025, our executive chair, Peter Chapman, has agreed with us that he will not sell more than 2,215,000 shares of our common stock beneficially owned by him, and our chief executive
officer, Niccolo De Masi, has agreed with us that he will not sell more than 1,600,000 shares of our common stock beneficially owned by him, which is fewer than the number of shares of our common stock that Mr. de Masi has been granted in equity
awards upon becoming our chief executive officer. In addition, during the same period covered by the preceding sentence, our chief financial officer, Thomas Kramer, has agreed with us that he will not sell more than 200,000 shares of our common
stock beneficially owned by him, and Inder Singh, one of our directors, has agreed with us that he will not sell more than 118,000 shares of our common stock beneficially owned by him. Mr. Chapman, Mr. de Masi, Mr. Kramer and Mr. Singh have also
agreed not to sell shares of common stock beneficially owned by them until the sale of $500.0 million in shares of our common stock pursuant to this prospectus supplement is complete, and we have asked our other directors and officers not to sell
during that period as well. Mr. Chapman, Mr. de Masi and Mr. Kramer have also agreed with us that they will conduct future market sales of their beneficially owned shares of common stock pursuant to approved 10b5-1 trading plans. We cannot predict the effect that future sales of our common stock or other equity-related securities, including by our directors and officers, or the effect that the timing of any such sales,
would have on the market price of our common stock.

It is not possible to predict the actual number of shares we will sell under the equity distribution agreement, or the gross proceeds resulting from those sales.

Subject to certain limitations in the equity distribution agreement and
compliance with applicable law, we have the discretion to deliver instruction to the sales agents to sell shares of our common stock at any time throughout the term of the equity distribution agreement. The number of shares, if any, that are sold
through, or to